United Guardian INC 8-K filings

United-Guardian announced robust financial results for the second quarter and first half of 2026, showcasing significant increases in net sales and net income.

United-Guardian announced a cash dividend of $0.30 per share, a 20% increase from the previous dividend, marking the 31st consecutive year of dividend payments.

United-Guardian, Inc. reported the results of its 2026 Annual Meeting of Stockholders, including the election of directors and advisory votes on executive compensation and auditor ratification.

United-Guardian, Inc. announced a significant increase in first-quarter 2026 sales and net income, driven by strong performance in its pharmaceutical and cosmetic ingredient segments.

United-Guardian, Inc. reported a 13% decrease in net sales and a significant drop in net income for fiscal year 2025, primarily due to reduced cosmetic ingredient sales.

United-Guardian's Board of Directors declared a $0.25 per share cash dividend, marking its 31st consecutive year of dividend payments.

United-Guardian, Inc. reported a significant decline in third-quarter and nine-month sales and net income for 2025, primarily due to reduced cosmetic ingredient purchases by its largest marketing partner, Ashland Specialty Ingredients.

United-Guardian, Inc. reported a significant decrease in net sales and net income for the second quarter and first half of 2025, primarily due to reduced cosmetic ingredient sales.

United-Guardian, Inc. announced a $0.25 per share cash dividend, marking its 30th consecutive year of payments, while also allocating capital for new growth initiatives in personal care and pharmaceutical sectors.

United-Guardian, Inc. appoints its President, Donna Vigilante, to the Board of Directors and updates its Code of Ethics to reflect current practices.

United-Guardian, Inc. held its 2025 Annual Meeting of Stockholders, where directors were elected, executive compensation was approved, and the company's accounting firm was ratified.

United-Guardian's first quarter sales and net income decreased in 2025 compared to 2024, primarily due to a significant drop in cosmetic ingredient sales.

United-Guardian, Inc. announces a 12% increase in net sales and a rise in net income for fiscal year 2024, fueled by strong performance in cosmetic ingredients and medical lubricants.

United-Guardian has declared a cash dividend of $0.35 per share, marking its 30th consecutive year of dividend payments.

United-Guardian announced increased earnings for both the third quarter and the first nine months of 2024, driven by strong cosmetic ingredient sales.

United-Guardian, Inc. announced increased sales and net income for both the second quarter and first half of 2024, driven by strong growth in cosmetic ingredient sales.

United-Guardian has declared a cash dividend of $0.35 per share, a 40% increase from the previous dividend and a 250% increase year-over-year.

United-Guardian, Inc. has announced the appointment of Denise Costrini as their new marketing director, bringing over 25 years of experience in the personal care and specialty chemicals industries.

United-Guardian, Inc. held its 2024 Annual Meeting of Stockholders on May 15, 2024, where shareholders voted on key proposals including the election of directors and executive compensation.

United-Guardian's first quarter 2024 sales increased by 27% year-over-year, with net income also rising significantly.

United-Guardian's net income remained relatively flat in 2023 compared to 2022, despite a 14% decrease in net sales.

United-Guardian, Inc. has entered into a six-year manufacturing and supply agreement with Amsino Healthcare (USA), Inc. for its Renacidin Irrigation product, effective January 1, 2023.

United-Guardian has declared a $0.25 per share dividend, a significant increase from the $0.10 per share paid in 2023, marking the 29th consecutive year of dividend payments.